Hepatitis e

N Kamar, R Bendall, F Legrand-Abravanel, NS Xia… - The Lancet, 2012 - thelancet.com
Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …

Hepatitis E virus infection

N Kamar, HR Dalton, F Abravanel… - Clinical microbiology …, 2014 - Am Soc Microbiol
Hepatitis E virus (HEV) infection is a worldwide disease. An improved understanding of the
natural history of HEV infection has been achieved within the last decade. Several reservoirs …

Hepatitis E virus infection

N Kamar, J Izopet, N Pavio, R Aggarwal… - Nature Reviews …, 2017 - nature.com
Hepatitis E virus (HEV) infection can lead to acute and chronic hepatitis as well as to extrahepatic
manifestations such as neurological and renal disease; it is the most common cause of …

Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients

N Kamar, F Abravanel, O Marion, C Couat… - … England Journal of …, 2021 - Mass Medical Soc
Three Covid-19 Vaccine Doses in Transplant Recipients Solid-organ transplant recipients
receiving immunosuppressive therapy appear to have a poor response to Covid-19 …

[HTML][HTML] Hepatitis E virus and chronic hepatitis in organ-transplant recipients

N Kamar, J Selves, JM Mansuy… - … England Journal of …, 2008 - Mass Medical Soc
<p id="p001">Hepatitis E virus (HEV) is considered an agent responsible for acute hepatitis
that does not progress to chronic hepatitis. We identified 14 cases of acute HEV infection in …

Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

N Kamar, C Garrouste, EB Haagsma, V Garrigue… - Gastroenterology, 2011 - Elsevier
Background & Aims Hepatitis E virus (HEV) infection can cause chronic hepatitis in recipients
of solid organ transplants. However, the factors that contribute to chronic infection and the …

[HTML][HTML] Ribavirin for chronic hepatitis E virus infection in transplant recipients

N Kamar, J Izopet, S Tripon, M Bismuth… - … England Journal of …, 2014 - Mass Medical Soc
Background There is no established therapy for hepatitis E virus (HEV) infection. The aim of
this retrospective, multicenter case series was to assess the effects of ribavirin as …

[HTML][HTML] Hepatitis E virus antibodies in blood donors, France

…, V Ellis, H Rech, F Destruel, N Kamar… - Emerging infectious …, 2011 - ncbi.nlm.nih.gov
Using a validated sensitive assay, we found hepatitis E virus (HEV) IgG in 52.5% of voluntary
blood donors in southwestern France. This finding suggests HEV is highly endemic to this …

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

…, O Thaunat, T Legris, V Moal, PF Westeel, N Kamar… - Kidney international, 2020 - Elsevier
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

[HTML][HTML] Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation

…, E Morelon, F Buron, L Rostaing, N Kamar… - Kidney international, 2015 - Elsevier
Although cold ischemia time has been widely studied in renal transplantation area, there is
no consensus on its precise relationship with the transplantation outcomes. To study this, we …